Human Genome Epidemiology Literature Finder
Records 1 - 25 (of 25 Records) |
Query Trace: Carcinoma and IDH1[original query] |
---|
Identification of several novel non-p.R132 IDH1 variants in thyroid carcinomas. European journal of endocrinology / European Federation of Endocrine Societies 2010 Nov 163 (5): 747-55. Hemerly Jefferson Pessoa, Bastos André Uchimura, Cerutti Janete |
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. The oncologist 2012 17 (1): 72-9. Borger Darrell R, Tanabe Kenneth K, Fan Kenneth C, Lopez Hector U, Fantin Valeria R, Straley Kimberly S, Schenkein David P, Hezel Aram F, Ancukiewicz Marek, Liebman Hannah M, Kwak Eunice L, Clark Jeffrey W, Ryan David P, Deshpande Vikram, Dias-Santagata Dora, Ellisen Leif W, Zhu Andrew X, Iafrate A Jo |
Isocitrate dehydrogenase mutation hot spots in acute lymphoblastic leukemia and oral cancer. The Kaohsiung journal of medical sciences 2012 Mar 28 (3): 138-44. Tang Jen-Yang, Chang Chun-Chi, Lin Pei-Chin, Chang Jan-Gow |
Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma. BMC cancer 2013 13 (1): 79. Santos Juliana Carvalho, Bastos André Uchimura, Cerutti Janete Maria, Ribeiro Marcelo Li |
IDH1 p.R132 mutations may not be actively involved in the carcinogenesis of hepatocellular carcinoma. Medical science monitor : international medical journal of experimental and clinical research 2014 20 247-54. Lu Jun, Xu Ling, Zou Yang, Yang Run-Xiang, Fan Yu, Zhang Wen, Yu Dandan, Yao Yong-Ga |
Absence of DICER1, CTCF, RPL22, DNMT3A, TRRAP, IDH1 and IDH2 hotspot mutations in patients with various subtypes of ovarian carcinomas. Biomedical reports 2015 Jan 3 (1): 33-37. Zou Yang, Huang Mei-Zhen, Liu Fa-Ying, Yang Bi-Cheng, Wang Li-Qun, Wang Feng, Yu Xiao-Hong, Wan Lei, Wan Xi-DI, Xu Xiao-Yun, Li Wei, Huang Ou-Ping, He Mi |
Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients. Medical oncology (Northwood, London, England) 2014 Nov 31 (11): 278. Zhang Huiqing, Guo Xu, Dai Jingyao, Wu Yousheng, Ge Naijian, Yang Yefa, Ji Jiansong, Zhang Hongx |
HMGA2 expression pattern and TERT mutations in tumors of the vulva. Oncology reports 2015 Jun 33 (6): 2675-80. Agostini Antonio, Panagopoulos Ioannis, Andersen Hege Kilen, Johannesen Lene Elisabeth, Davidson Ben, Tropé Claes Göran, Heim Sverre, Micci Frances |
Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas. The Journal of pathology 2017 May . Dogan Snjezana, Chute Deborah J, Xu Bin, Ptashkin Ryan N, Chandramohan Raghu, Casanova-Murphy Jacklyn, Nafa Khedoudja, Bishop Justin A, Chiosea Simion I, Stelow Edward B, Ganly Ian, Pfister David G, Katabi Nora, Ghossein Ronald A, Berger Michael |
Clinicopathological, radiologic, and molecular study of 23 combined hepatocellular-cholangiocarcinomas with stem cell features, cholangiolocellular type. Human pathology 2017 Apr . Chen Jun, He Jian, Deng Min, Wu Hong-Yan, Shi Jiong, Mao Liang, Sun Qi, Tang Min, Fan Xiang-Shan, Qiu Yu-Dong, Huang Q |
Clinicopathological and genetic characteristics of pulmonary large cell carcinoma under 2015 WHO classification: a pilot study. Oncotarget 2017 Nov 8 (59): 100754-100763. Liu Renwang, Liu Jinghao, Shi Tao, Li Xiongfei, Ren Dian, Chen Gang, Li Ying, Liu Hongyu, Xu Song, Chen J |
Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study. Current oncology (Toronto, Ont.) 2017 1 23 (6): e571-e575. Sheffield B S, Tessier-Cloutier B, Li-Chang H, Shen Y, Pleasance E, Kasaian K, Li Y, Jones S J M, Lim H J, Renouf D J, Huntsman D G, Yip S, Laskin J, Marra M, Schaeffer D |
Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation. Inflammatory bowel diseases 2018 May . Hartman Douglas J, Binion David G, Regueiro Miguel D, Miller Caitlyn, Herbst Cameron, Pai Reetesh |
Molecular genomic landscapes of hepatobiliary cancer. Cancer science 2018 3 109 (5): 1282-1291. Shibata Tatsuhiro, Arai Yasuhito, Totoki Yasus |
Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia (New York, N.Y.) 2018 Feb 20 (3): 256-262. Shajani-Yi Zahra, de Abreu Francine B, Peterson Jason D, Tsongalis Gregory |
Cholangiolocellular Carcinoma With "Ductal Plate Malformation" Pattern May Be Characterized by ARID1A Genetic Alterations. The American journal of surgical pathology 2018 12 43 (3): 352-360. Sasaki Motoko, Sato Yasunori, Nakanuma Yasu |
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 10 25 (7): 2116-2126. Harding James J, Nandakumar Subhiksha, Armenia Joshua, Khalil Danny N, Albano Melanie, Ly Michele, Shia Jinru, Hechtman Jaclyn F, Kundra Ritika, El Dika Imane, Do Richard K, Sun Yichao, Kingham T Peter, D'Angelica Michael I, Berger Michael F, Hyman David M, Jarnagin William, Klimstra David S, Janjigian Yelena Y, Solit David B, Schultz Nikolaus, Abou-Alfa Ghassan |
Crossing borders: A systematic review with quantitative analysis of genetic mutations of carcinomas of the biliary tract. Critical reviews in oncology/hematology 2019 6 140 8-16. Roos E, Soer E C, Klompmaker S, Meijer L L, Besselink M G, Giovannetti E, Heger M, Kazemier G, Klümpen H J, Takkenberg R B, Wilmink H, Würdinger T, Dijk F, van Gulik T M, Verheij J, van de Vijver M |
Keratin 19-expressing hepatocellular carcinoma and small-duct type intrahepatic cholangiocarcinoma show a similar postoperative clinical course but have distinct genetic features. Histopathology 2019 4 75 (3): 385-393. Akita Masayuki, Ajiki Tetsuo, Fukumoto Takumi, Itoh Tomoo, Zen Y |
Distinctive clinicopathological features and KRAS and IDH1/2 mutation status of cholangiolocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 2019 Nov . Kusano Hironori, Naito Yoshiki, Mihara Yutaro, Kondo Reiichiro, Ogasawara Sachiko, Akiba Jun, Nakashima Osamu, Yano Hirohi |
Identifying Genomic Alterations in Patients With Stage IV Breast Cancer Using MammaSeq: An International Collaborative Study. Clinical breast cancer 2020 11 21 (3): 210-217. Shah Osama Shiraz, Soran Atilla, Sahin Mustafa, Knapick Beth A, Ugras Serdar, Celik Esin, Lucas Peter C, Lee Adrian |
Multiomics analysis of tumor mutational burden across cancer types. Computational and structural biotechnology journal 2021 19 5637-5646. Li Lin, Bai Long, Lin Huan, Dong Lin, Zhang Rumeng, Cheng Xiao, Liu Zexian, Ouyang Yi, Ding Kesh |
Molecular characterization-based multi-omics analyses in primary liver cancer using the Japanese version of the genome atlas. Journal of hepato-biliary-pancreatic sciences 2022 8 . Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Nagashima Takeshi, Yamaguchi K |
Isocitrate Dehydrogenase 1 and 2 Mutations in Pediatric Neuroblastoma Patients. Medeniyet medical journal 2023 6 38 (2): 102-110. Emre Leventoglu, Gurses Sahin, Sule Yesil, Ceyhun Bozkurt, Nazmiye Yuksek, Ali Fettah, Sule Toprak, Burcak Kurucu Bilgin, Emre Capkinoglu, Nilgun Eroglu, Sibel Akpinar Tekgunduz, Ayse Ulya Ert |
TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Advances in therapy 2024 1 . Sergio D Cruz-Romero, Sebastián González, José Y Juez, David S Becerra, Ana M Baldión, José A Hakim, Deyanira González-Devia, Sandra Perdomo, Paula A Rodríguez-Urre |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: